Two new webinars offer families insight on SCID

Severe Combined Immunodeficiency (SCID) is one of the most severe forms of primary immunodeficiency (PI). Affected infants appear healthy at birth, but the diagnosis can be fatal without early detection. Screening all children born in the U.S. for SCID is now required in all 50 states, but many families may wonder what happens after diagnosis? Learn more about these rare diagnoses by watching two IDF webinars about SCID from the perspectives of a parent and a physician.

In the first of two webinars, Nicole, the mother of a son diagnosed with SCID detected through newborn screening, explains her family’s experience while answering questions and offering advice to other families facing similar challenges. Click here to view the webinar.

Next, Donald Kohn, MD, Professor of Microbiology, Immunology and Molecular Genetics and Pediatrics at The University of California, Los Angeles (UCLA) leads IDF’s second webinar to discuss background information and treatment options for ADA-SCID, a type of SCID caused by mutations in a gene that encodes an enzyme called adenosine deaminase (ADA). Click here to watch the webinar featuring Dr. Kohn.

These webinars were supported by Leadiant Biosciences.

This article originally appeared in the IDF monthly e-newsletter, Primary Immune Tribune. Click here to subscribe.